Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2002
Effects of 5,6-dimethylxanthenone-4-acetic acid on human tumor microcirculation assessed by dynamic contrast-enhanced magnetic resonance imagingSusan M Galbraith, Gordon J S Rustin, Martin A Lodge, et al.
Journal of Computer Assisted Tomography|March 31, 2010
Improved characterization of focal liver lesions with liver-specific gadoxetic acid disodium-enhanced magnetic resonance imaging: a multicenter phase 3 clinical trialSteven S Raman, Christopher Leary, David A Bluemke, et al.
Neuropsychiatric Disease and Treatment|September 2, 2017
Efficacy and safety of paliperidone palmitate three-monthly formulation in East Asian patients with schizophrenia: subgroup analysis of a global, randomized, double-blind, Phase III, noninferiority studyAdam J Savitz, Haiyan Xu, Srihari Gopal, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|November 9, 2021
Comparison of Long-Term Efficacy and Safety of Esketamine Nasal Spray Plus Oral Antidepressant in Younger Versus Older Patients With Treatment-Resistant Depression: Post-Hoc Analysis of SUSTAIN-2, a Long-Term Open-Label Phase 3 Safety and Efficacy StudyRachel Ochs-Ross, Ewa Wajs, Ella J Daly, et al.
Radiology|July 15, 2025
SAR Consensus Recommendations for Defining Small Bowel Crohn Disease Strictures at CT and MR EnterographyBari Dane, Jonathan R Dillman, Jeff Fidler, et al.
Inflammatory Bowel Diseases|May 23, 2018
Clinical Benefit of Capsule Endoscopy in Crohn's Disease: Impact on Patient Management and Prevalence of Proximal Small Bowel InvolvementStephanie L Hansel, Jeffrey D McCurdy, John M Barlow, et al.
The American Journal of Psychiatry|May 22, 2019
Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled StudyVanina Popova, Ella J Daly, Madhukar Trivedi, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|November 18, 2019
Efficacy and Safety of Esketamine Nasal Spray Plus an Oral Antidepressant in Elderly Patients With Treatment-Resistant Depression-TRANSFORM-3Rachel Ochs-Ross, Ella J Daly, Yun Zhang, et al.
The International Journal of Neuropsychopharmacology|July 11, 2019
Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1)Maggie Fedgchin, Madhukar Trivedi, Ella J Daly, et al.
The Journal of Clinical Psychiatry|April 22, 2020
Esketamine Nasal Spray Plus Oral Antidepressant in Patients With Treatment-Resistant Depression: Assessment of Long-Term Safety in a Phase 3, Open-Label Study (SUSTAIN-2)Ewa Wajs, Leah Aluisio, Richard Holder, et al.
Pageof 8